Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Not covered under the Bridge: compounded semaglutide or tirzepatide, Saxenda (liraglutide), and any off-label GLP-1 use
Semaglutide-based products are approved for Type 2 Diabetes and weight management, and FDA labeling states they are not for the treatment of Type 1 Diabetes
When using in the morning, follow with sunscreen to help protect the skin
There are post marketing reports of acute kidney injury and worsening of chronic renal failure
Vial appearance, label, seal and cap colors may vary from product photos
US$ 25.30
US$ 25.47
US$ 29.92
US$ 27.11
US$ 28.11
